JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Intuitive Surgical Inc

Closed

SectorHealthcare

495.83 1.55

Overview

Share price change

24h

Current

Min

493.21

Max

495.96

Key metrics

By Trading Economics

Income

16M

704M

Sales

-160M

2.3B

P/E

Sector Avg

75.346

38.156

EPS

1.81

Profit margin

31.228

Employees

15,638

EBITDA

-91M

719M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+22.13% upside

Dividends

By Dow Jones

Next Earnings

16 Oct 2025

Market Stats

By TradingEconomics

Market Cap

-25B

185B

Previous open

494.28

Previous close

495.83

News Sentiment

By Acuity

34%

66%

78 / 375 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Intuitive Surgical Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Jul 2025, 21:13 UTC

Earnings

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 Apr 2025, 20:55 UTC

Earnings

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 Jan 2025, 21:41 UTC

Earnings

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 Jan 2025, 18:37 UTC

Acquisitions, Mergers, Takeovers

Intuitive to Establish Direct Presence in Europe With Acquisition

22 Jul 2025, 20:14 UTC

Earnings

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 Jul 2025, 20:13 UTC

Earnings

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 Jul 2025, 20:13 UTC

Earnings

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 Jul 2025, 20:05 UTC

Earnings

Intuitive Surgical 2Q Net $658.4M >ISRG

22 Jul 2025, 20:05 UTC

Earnings

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 Jul 2025, 20:05 UTC

Earnings

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 Jul 2025, 20:05 UTC

Earnings

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 Jul 2025, 20:05 UTC

Earnings

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 Apr 2025, 20:13 UTC

Earnings

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 Apr 2025, 20:05 UTC

Earnings

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 Apr 2025, 20:05 UTC

Earnings

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 Apr 2025, 20:05 UTC

Earnings

Intuitive Surgical 1Q Net $698.4M >ISRG

22 Apr 2025, 20:05 UTC

Earnings

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 Apr 2025, 20:05 UTC

Earnings

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 Jan 2025, 21:17 UTC

Earnings

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 Jan 2025, 18:18 UTC

Earnings

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 Jan 2025, 13:11 UTC

Top News

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 Jan 2025, 09:51 UTC

Hot Stocks

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 Jan 2025, 21:10 UTC

Earnings

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 Jan 2025, 21:09 UTC

Earnings

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 Jan 2025, 21:09 UTC

Earnings

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 Jan 2025, 21:05 UTC

Earnings

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 Jan 2025, 21:05 UTC

Earnings

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 Jan 2025, 21:05 UTC

Earnings

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 Jan 2025, 21:05 UTC

Earnings

Intuitive Surgical 4Q Net $685.7M >ISRG

23 Jan 2025, 21:05 UTC

Earnings

Intuitive Surgical 4Q EPS $1.88 >ISRG

Peer Comparison

Price change

Intuitive Surgical Inc Forecast

Price Target

By TipRanks

22.13% upside

12 Months Forecast

Average 605.61 USD  22.13%

High 685 USD

Low 440 USD

Based on 22 Wall Street analysts offering 12 month price targets forIntuitive Surgical Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

22 ratings

16

Buy

5

Hold

1

Sell

Technical Score

By Trading Central

514.59 / 539.05Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

78 / 375 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.